Department of Orthopaedics and Sports Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Lilly Research Laboratories, Eli Lilly Pharmaceuticals, Indianapolis, IN, USA.
Cartilage. 2021 Dec;13(2_suppl):168S-174S. doi: 10.1177/19476035211021907. Epub 2021 Jun 24.
In osteoarthritis, chondrocytes tend to acquire a hypertrophic phenotype, which contributes to the modification of the extracellular matrix, resulting in permanent cartilage changes. In mouse chondrocytes, pro-inflammatory macrophages and pro-inflammatory cytokines have been shown to stimulate hypertrophy via the activation of the nuclear factor kappa B (NF-κB) pathway. Whether or not this also occurs in human chondrocytes remains unclear. We therefore aimed to investigate whether hypertrophy-like responses in human cartilage are driven mainly by intrinsic inflammatory signaling or shaped by specific macrophage populations.
Human articular chondrocytes were cultured with pro-inflammatory cytokines or medium conditioned by defined macrophage subsets. Furthermore, the effect of inhibition of NF-κB-dependent gene expression was evaluated using the NF-κB inhibitor SC-514. Hypertrophy was assessed by measuring the transcription level of alkaline phosphatase (), type X collagen (), Indian hedgehog (), and runt-related transcription factor 2 ().
The expression of hypertrophic genes was not promoted in human chondrocytes by pro-inflammatory cytokines neither pro-inflammatory M(IFNγ + TNFα) macrophages. Inhibition of the NF-κB-dependent gene expression did not affect human articular chondrocyte hypertrophy. However, tissue repair M(IL4) macrophages induced hypertrophy by promoting the expression of , , and .
Intrinsic inflammatory signaling activation is not involved in the hypertrophic shift observed in human articular chondrocytes cultured . However, tissue repair macrophages may contribute to the onset of this detrimental phenotype in human osteoarthritic cartilage, given the effect observed in our experimental models.
在骨关节炎中,软骨细胞往往会获得肥大表型,这有助于细胞外基质的修饰,导致永久性软骨变化。在小鼠软骨细胞中,促炎巨噬细胞和促炎细胞因子已被证明通过激活核因子 kappa B(NF-κB)途径刺激肥大。这种情况是否也发生在人类软骨细胞中尚不清楚。因此,我们旨在研究人类软骨中的肥大样反应主要是由内在炎症信号驱动的,还是由特定的巨噬细胞群体塑造的。
用促炎细胞因子或特定巨噬细胞亚群条件培养基培养人关节软骨细胞。此外,还使用 NF-κB 抑制剂 SC-514 评估了抑制 NF-κB 依赖性基因表达的效果。通过测量碱性磷酸酶 (), 型 X 胶原 (), 印度刺猬 (), 和 runt 相关转录因子 2 () 的转录水平来评估肥大。
促炎细胞因子和促炎 M(IFNγ + TNFα)巨噬细胞均未促进人软骨细胞中肥大基因的表达。NF-κB 依赖性基因表达的抑制并不影响人关节软骨细胞的肥大。然而,组织修复 M(IL4) 巨噬细胞通过促进 的表达诱导肥大 , 和 。
在培养的人关节软骨细胞中,内在炎症信号激活不参与观察到的肥大转变。然而,鉴于我们的实验模型中的观察结果,组织修复巨噬细胞可能导致人骨关节炎软骨中这种有害表型的发生。